Molecular Oncology

Molecular oncology refers to the chemistry of cancer and tumours at the molecular scale and their development and application on molecularly targeted therapies.

Molecular Oncology studies especially the genetic alterations and their implications. Molecular Oncology focuses on new discoveries, approaches, as well as technical developments in basic, clinical and discovery-driven cancer research. It mainly focuses on advances in the understanding of disease processes leading to human tumour development. Molecular Oncology establishes novel concepts of clear clinical significance in diagnosis, prognosis and prevention strategies.

• DNA repair
• Apoptosis
• Cancer genetics
• Molecular pathology
• Tumour immunology

Molecular Medicine

Atomic prescription is an expansive field which manages the improvement of illnesses at a sub-atomic level and distinguishes crucial sub-atomic and hereditary blunders of infection and to create sub-atomic intercessions to address them. Sub-atomic structures and components are portrayed by physical, compound, organic, bioinformatics and medicinal methods. Illness pathogenesis at the atomic or physiological level may prompt the structure of explicit devices for infection determination, treatment, or anticipation.

By understanding the qualities, proteins, and other cell atoms work sub-atomic medication creates approaches to analyse and treat illness. Atomic medicine creates information and abilities in cell and sub-atomic science Atomic Medicine Cancer

Immunotherapy

Due to chop-chop advancing field of cancer medical specialty in past few years, there has been production of the many new methods of treating cancer called Immunotherapies. Medical aid is also a style of treatment that will increase the strength of immune reaction against tumours either by stimulating the activities of specific elements of system or by counteracting signals created by cancer cells that suppress immune responses. Some sorts of therapy also are called as biological medical aid or biotherapy. Recent advancements in cancer immunotherapy’s have provided new therapeutic approaches. These embody tumor-associated macrophages as treatment targets in medicine, unmoved activation of platelets with stop inhibitors for post-surgical cancer therapy, immune stop blockade and associated endocrinopathies  and plenty of additional. There are several types of Immunotherapy. They are:

• Monoclonal Antibodies and tumor-agnostic therapies
• Non-specific Immunotherapies
• Oncolytic virus therapy
• T-cell Therapy
• Cancer Vaccines

The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded online at Editorial Tracking System (https://www.longdom.org/editorial-tracking/publisher.php) or forwarded to the Editorial Office at  https://www.longdom.org/eye-diseases-and-disorders.html

 The Journals includes around 150Abstracts and 100 Keynote speakers have given their valuable words. The meet has provided a great scope for interaction of professionals including in addition to clinical experts and top-level pathologists and scientists from around the globe, on a single platform.
 

Media Contact:
ALPINE
Managing Editor
Journal of Molecular Oncology Research
Email: oncology@openaccessjournal.org
Watsapp:+ +44-1470-490003